Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China | |
Zhou, Lei; Liu, Weibin; Li, Wei; Li, Haifeng; Zhang, Xu; Shang, Huifang; Zhang, Xu; Bu, Bitao; Deng, Hui; Fang, Qi | |
刊名 | THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS |
2017 | |
卷号 | 10期号:9页码:315-325 |
关键词 | immunology myasthenia gravis tacrolimus |
DOI | 10.1177/1756285617721092 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4590198 |
专题 | 山东大学 |
作者单位 | 1.Fudan Univ, Huashan Hosp, Dept Neurol, 12 Wulumuqi Middle Rd, Shanghai 200040, Peoples R China. 2.[Liu, Weibi |
推荐引用方式 GB/T 7714 | Zhou, Lei,Liu, Weibin,Li, Wei,et al. Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China[J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS,2017,10(9):315-325. |
APA | Zhou, Lei.,Liu, Weibin.,Li, Wei.,Li, Haifeng.,Zhang, Xu.,...&Z 更多.(2017).Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China.THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS,10(9),315-325. |
MLA | Zhou, Lei,et al."Tacrolimus in the treatment of myasthenia gravis in patients with an inadequate response to glucocorticoid therapy: randomized, double-blind, placebo-controlled study conducted in China".THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS 10.9(2017):315-325. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论